Who is sponsoring NCT02708537?

NCT02708537 is sponsored by IVI Bilbao.

What condition does NCT02708537 study?

NCT02708537 studies Vascular Endothelial Growth Factor Overexpression.

What drugs are being tested in NCT02708537?

Interventions: PRGF in candidates for sperm donors.

What is the status of NCT02708537?

NCT02708537 is currently COMPLETED.

Last reviewed 2022-07-29 · How we verify

Effect of Plasma Rich in Growth Factors (PRGF) on Semen Quality

NCT02708537 COMPLETED

The hypothesis is growing semen samples with plasma rich in growth factors (PRGF), because it could improve sperm motility in patients subsidiary TRA, ultimately improving pregnancy rates.

Details

Lead sponsor	IVI Bilbao
Status	COMPLETED
Enrolment	20
Start date	2016-04
Completion	2017-12

Conditions

Vascular Endothelial Growth Factor Overexpression

Interventions

PRGF in candidates for sperm donors

Primary outcomes

Evaluate the percentage of motile sperm adding PRGF versus those samples that growth factors were not added — 6 months
Within concerted donor visits in IVI Bilbao will be held: * Removing Blood 9 mL of blood to obtain plasma rich in factors growth * Seminogram to analyze all semen parameters according to the criteria of the WHO (2010), paying particular attention to sperm motility. * Sperm vitality will be analyzed before and after treatment with PRGF. PRGF application on the seminal aliquots will be conducted at different concentrations assessing sperm motility.

Countries

Spain